ASRT Stock Analysis: Buy, Sell, or Hold?
ASRT - Assertio Holdings, Inc. Common Stock
$23.50
0.02 (0.09%)
▲
5d:
+0.3%
30d:
+0.77%
90d:
+99.66%
HOLD
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When ASRT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ASRT trades at premium valuation expecting 9.0% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: ASRT trades at premium valuation expecting 9.0% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$25.31
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$15.71
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ASRT is currently trading at $23.50, which is considered extended relative to its 30-day fair value range of $23.40 to $23.48. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.1) compared to its historical average (7.0). At these levels, the market is pricing in 9.0% annual earnings growth.
Technical Outlook: Technically, ASRT is in a strong uptrend. The price is currently testing key support at $23.41. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (28th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ASRT is in a strong uptrend. The price is currently testing key support at $23.41. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (28th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$23.40 -
$23.48
Company Quality Score
52/100
(HOLD)
Options IV Signal
28th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
59.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 28th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($24.43)
- BULLISH: Expecting earnings turnaround to 9.0% growth with -62.5% revenue growth
Trading Range Analysis
30-Day Trading Range
$23.40 -
$23.48
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.15
(9.1%)
Support & Resistance Levels
Support Level
$23.41
Resistance Level
$23.50
Current Trend
Strong Uptrend
Technical data as of
Jun 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.11
Wall Street Target
$24.43
(+4.0%)
Revenue Growth (YoY)
-62.5%
Earnings Growth (YoY)
-18.8%
Profit Margin
-34.9%
Valuation Premium vs History
+9.0% premium
PE vs Historical
9.1 vs 7.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.0%
(market-implied from PE analysis)
1-Year Target
$25.62
(+9%)
2-Year Target
$27.92
(+19%)
3-Year Target
$30.43
(+30%)
3-Yr Target (if PE normalizes)
(PE: 9→7)
PE COMPRESSION
$23.39
(-1%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: June 24, 2026 1:21 AM ET
Data refreshes hourly during market hours. Next update: 2:21 AM
Data refreshes hourly during market hours. Next update: 2:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ASRT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 60 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 64 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 58 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 57 HOLD |
